The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors

NCT05821751 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DIETARY_SUPPLEMENT: inulin
DRUG: Pembrolizumab
DRUG: Nivolumab

Sponsor

Fondazione del Piemonte per l'Oncologia

Collaborators

[object Object]
[object Object]